A new Mayo Clinic study indicates that ovarian cancer patients with diabetes who took the drug metformin for the diabetes had an increased cancer survival rate, MPR reports.
A Mayo press release says "Metformin is a widely prescribed drug to treat diabetes, and previous research by others has shown its promise for other cancers. The Mayo-led study adds ovarian cancer to the list."
Mayo studied 63 diabetic patients being treated with metformin, 67 diabetic patients not receiving metformin, and 1318 nondiabetic patients.
The findings of the study by the Rochester-based Mayo were published in the online journal Cancer.